Alina Su, Chief Executive Officer and Co-Founder of NovaXS, is an innovator who is passionate about creating technology that makes healthcare equal and accessible to all. An entrepreneur and inventor, Ms Su holds six medical device patents in China and the US with three more patent applications pending. She is a PhD student studying Biological and Biomedical Science at Harvard Medical School and holds a BS in Bioengineering
and Biomedical Engineering from the University of California, Berkeley. Ms Su has held researcher roles at Quantitative Biosciences Conboy Labs, UCSF Catalyst Program, Cellular Biomedicine Group and Serrento Therapeutics. She is the author of numerous scientific publications.